Which has grown faster, HOLX or MRNA?

Over the past five years, HOLX grew revenue faster — HOLX at a -1.87% CAGR versus MRNA at -2.60%.

Is HOLX or MRNA more profitable?

HOLX runs the higher net margin — HOLX at 13.18% versus MRNA at -143.55%.

Which has been the better investment, HOLX or MRNA?

Over the past 5-year, HOLX delivered the higher annualized total return — HOLX at 7.99% versus MRNA at -25.58%. Past performance doesn't predict future results.

Hologic, Inc. (HOLX) vs Moderna, Inc. (MRNA)

HOLX leads on 8 of 10 compared metrics.

A side-by-side comparison of Hologic, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — HOLX vs MRNA

growth of $100 · last 7y

HOLX +81.1%MRNA +169.4%MRNA compounded faster

HOLX MRNA

HOLX vs MRNA: by the numbers

•MRNA is the larger company ($19.80B vs $16.97B market cap).
•HOLX is profitable (13.18% net margin) while MRNA runs a net loss (-143.55%).
•HOLX grew revenue faster over the past five years (-1.87% vs -2.60% CAGR).

Which is better, HOLX or MRNA?

Metric tally: HOLX 8 · MRNA 2

It depends on what you're optimizing for:

GrowthHOLX(faster 5Y revenue CAGR)

QualityHOLX(higher ROIC)

Valuation

Metric	HOLX	MRNA
P/E ratio	31.67	—
Forward P/E	17.21	—
P/S ratio	4.16●	8.86
P/B ratio	3.27	2.66●
EV / EBITDA	17.28	—
FCF yield	5.82%	—

Profitability

Metric	HOLX	MRNA
Gross margin	52.82%●	-13.89%
Operating margin	17.49%●	-153.35%
Net margin	13.18%●	-143.55%
ROE	10.37%●	-43.12%
ROIC	7.35%●	-29.70%

Growth (annualized)

Metric	HOLX	MRNA
Revenue CAGR (5Y)	-1.87%●	-2.60%
EPS CAGR (5Y)	-0.96%	—
FCF CAGR (5Y)	-4.57%	126.92%●
Total return CAGR (5Y)	0.84%●	-25.58%

Frequently asked

Which is better, HOLX or MRNA?: It depends on your goal. growth: HOLX (faster 5Y revenue CAGR); quality: HOLX (higher ROIC). Across all compared metrics, HOLX leads 8 to 2.
Which has grown faster, HOLX or MRNA?: Over the past five years, HOLX grew revenue faster — HOLX at a -1.87% CAGR versus MRNA at -2.60%.
Is HOLX or MRNA more profitable?: HOLX runs the higher net margin — HOLX at 13.18% versus MRNA at -143.55%.
Which has been the better investment, HOLX or MRNA?: Over the past 5-year, HOLX delivered the higher annualized total return — HOLX at 7.99% versus MRNA at -25.58%. Past performance doesn't predict future results.

Go deeper

Full HOLX analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Hologic P/E ratio Moderna P/E ratio Hologic dividend yield Moderna dividend yield Hologic ROE Moderna ROE Hologic operating margin Moderna operating margin Hologic revenue growth Moderna revenue growth Hologic free cash flow Moderna free cash flow

Hologic & Moderna appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.